Interleukin-33 levels in systemic lupus erythematosus
Part of Immune system & allergy clinical trials.
This study looks at whether a protein in the blood called interleukin-33 is linked to lupus symptoms)Skip
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of systemic lupus erythematosus (SLE).
- If you have lupus nephritis, it must be confirmed by a kidney biopsy or other tests.
- You cannot have other autoimmune diseases, chronic infections, or cancer.
- Pregnant or breastfeeding women are not eligible.
- You cannot have end-stage kidney disease or be on dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood test results in people with lupus compared to healthy people. It may help doctors understand lupus better and improve care.
This study looks at whether a protein called uromodulin (found in urine and blood) can help tell how active lupus nephritis is. It compares different groups of people with and without kidney problems to find better ways to diagnose and manage the condition.
This study looks at whether certain substances in the blood, such as uric acid, homocysteine, and interleukin-17, are higher in people with lupus-related kidney disease compared to healthy individuals. It aims to find new ways to monitor or understand the condition better.
This trial looks at a protein called interleukin-23 in people with lupus, especially those who also have lung inflammation (interstitial lung disease). The goal is to understand more about this protein's role and possibly find new ways to help.
This study looks at a marker called IL-33 in the blood of people with moderate to severe psoriasis. It aims to see if IL-33 levels are different in psoriasis and might help guide future treatments.
This study looks at a simple blood test (called the Systemic Immune Inflammatory Index) to see if it can help doctors understand how active lupus is in your body. It includes people with lupus, especially those with kidney involvement, to find better ways to track the disease.
Hear when a new SLE trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.